What is MREO stock price today?

Visit our real-time dashboard for the current MREO stock price and live market data.

Is MREO stock going up or down today?

MREO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MREO stock now?

The decision to buy MREO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MREO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MREO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MREO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MREO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MREO's P/E ratio?

P/E ratio data for MREO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MREO's market cap?

MREO (Mereo BioPharma Group PLC ADR) has a market capitalization of $0.05 billion, making it a small-cap stock.

What is MREO's price to book ratio?

Price-to-book ratio for MREO is available on our dashboard along with other valuation metrics.

Does MREO pay dividends?

MREO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MREO's dividend yield?

MREO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MREO stock a good long-term investment?

MREO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MREO's revenue growth rate?

Revenue growth data for MREO is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MREO are available on our dashboard with complete income statement analysis.

What are the risks of investing in MREO?

Key risks for MREO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MREO compare to its competitors?

Compare MREO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MREO's performance and positioning.

What is MREO's stock price target for 2026?

Visit our prediction page for AI-powered price targets for MREO with bull, base, and bear case scenarios.

What do analysts say about MREO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MREO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MREO's next earnings report?

MREO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MREO - Mereo BioPharma Group PLC ADR

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Mereo BioPharma Group PLC ADR

Mereo BioPharma Group PLC ADR (MREO) common stock

Price Chart

Loading chart...

MREO Key Statistics

Market Cap

$48.68M

How MREO Compares to Peers

MREO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MREO(This stock)	$48.68M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 25, 2026 at 10:16 AM EDT

Ready to invest in MREO?

Commission-free trading available. Affiliate links.

MREO Lician Score

5% confidence

4.0/10

Neutral

MREO has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates MREOacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

MREO Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for MREO

Dashboard

Enter a ticker to analyze